RHHBFRoche Holding Ltd

About Roche Holding Ltd (RHHBF)

Roche Holding Ltd (RHHBF) is a Drug Manufacturers - General company headquartered in Basel, Switzerland whose shares trade over-the-counter on the OTCQX tier.

Founded in1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalized healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognizing our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

Products and services

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. In recent years, Roche has invested in genomic profiling and real-world data partnerships and has become an industry-leading partner for medical insights.

RHHBF key facts

Ticker symbol

RHHBF

Market tier

OTCQX

Sector

Healthcare

Industry

Drug Manufacturers - General

Headquarters

Basel, Switzerland

Country of incorporation

CH

Year of incorporation

1896

Employees

10,361

Estimated market cap

$33.41B (as of Apr 11, 2025)

Shares outstanding

106,691,000

Reporting standard

International Reporting: SIX Swiss Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Roche Holding Ltd leadership

• Thomas Schinecker — CEO
• Teresa Graham — CEO
• Matt Sause — CEO
• Alan Hippe — CFO, CIO
• Cristina A. Wilbur — Chief Human Resources Officer
• Claudia Bockstiegel — General Counsel
• Sonya Schwab — Administrator
• Bruno Eschli — Head of IR

Explore more: Drug Manufacturers - General stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with R